NBC NewsIndependentCenterFactual 85Objective 807 days ago Eye drops recalled over possible contamination, FDA reportsThe U.S. Food and Drug Administration (FDA) has reported a voluntary recall of Clear Eyes Maximum Itchy Eye Relief eye drops due to potential contamination concerns. The 0.5-fluid-ounce bottles, distributed nationwide by Medtech Products under Prestige Consumer Healthcare, were labeled Lot 2552A and had a recall number of D-0766-2026 with an expiration date of September 30, 2027. No injuries have been reported, and the recall was initiated as a precautionary measure. The FDA classified the recall as Class II, indicating potential for temporary or medically reversible health issues, citing 'lack of assurance of sterility' as the cause. The recall includes 39,060 units and began on July 29, with ongoing efforts to remove the product from shelves.
Bias read (Center): The article presents a factual report on a voluntary recall of a medical product, focusing on regulatory actions and corporate responsibility. There is no overt ideological framing, and the tone remains neutral, emphasizing safety and regulatory compliance rather than political agendas. The coverage
Why factuality (85): The article accurately describes the recall as a Class II recall, citing the FDA notice and providing details such as the manufacturer, distribution, and specific lot numbers. It mentions the lack of confirmed contamination but explains the company's decision based on caution, which aligns with the
Why objectivity (80): The tone remains neutral, presenting facts from the FDA and the company's statement without overt bias. However, the phrase 'out of an abundance of caution' could imply a degree of concern beyond what is strictly factual, though it is presented as a business decision rather than an editorial stance.
Officials warn firefighters about the risks of using a supplement for smoke exposureFire and medical officials have issued warnings regarding the use of a supplement called glutathione among Western wildland firefighters exposed to toxic chemicals during major wildfires. The supplement, administered via IV or nebulizer, lacks proven safety or effectiveness and could pose health risks due to potential contamination during production. At least two pharmacies recalled the supplement in August after tests revealed bacterial contamination, with reports of symptoms such as fever, chills, and headaches. The International Association of Firefighters (IAFF), a labor union representing over 360,000 first responders, issued a safety advisory cautioning against unproven claims about glutathione's ability to treat or prevent disease. The supplement was previously offered to firefighters during the January 2025 wildfires in Los Angeles County and the 2017 California wine country fires. While some firefighters reported feeling better after using it, others experienced worsened symptoms. The IAFF emphasized the need for rigorous evaluation of any medical treatment marketed to firefighters to ensure safety. In response, representatives from the organization providing the glutathth
Bias read (Center): The article presents a balanced view of the controversy surrounding the use of glutathione among firefighters, citing both concerns raised by medical professionals and the experiences of some firefighters. It includes statements from the International Association of Firefighters warning against unv
Officials warn wildland firefighters about the risks of using a supplement for smoke exposureWildland firefighters in the U.S. have been warned about the potential dangers of using a supplement called glutathione to mitigate the effects of smoke exposure. The supplement, which is administered via IV or nebulizer, has not been approved by the FDA and has been linked to bacterial contamination in at least two recalls. Fire and medical officials, including the International Association of Firefighters, caution against its use due to lack of scientific validation and reported side effects such as fever, chills, and headaches. Glutathione was previously offered to firefighters during major wildfires in Spokane and Los Angeles, with some claiming it helped alleviate symptoms. However, medical professionals and officials have raised concerns over unproven health claims and potential harm. While some naturopaths acknowledge the need for further research, critics argue that the supplement should not be used without proper evaluation.
Bias read (Center): The article presents balanced reporting by citing both the concerns of fire officials and medical experts regarding the safety and efficacy of glutathione, as well as the perspectives of firefighters and naturopaths who support its use. There is no clear ideological slant toward either side, and the